Third-generation cephalosporin use is frequently non-guideline-concordant in severe community-acquired pneumonia: Findings from a French critical care cohort
Quitterie Lostie de Kerhor, Zeina Sabouni, Cyrille Geay, Catherine Bouvet-Velly, Laurent Ducros, Jonathan Chelly · 2026
Read Third-generation cephalosporin use is frequently non-guideline-concordant in severe community-acquired pneumonia: Findings from a French critical care cohort by Quitterie Lostie de Kerhor, Zeina Sabouni, Cyrille Geay, Catherine Bouvet-Velly, Laurent Ducros, Jonathan Chelly (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354339.txt.
Description
Quitterie Lostie de Kerhor leads a 2026 PLOS ONE audit of antibiotic choices in severe lung infection at a French intensive care unit. Severe community-acquired pneumonia, caught outside hospital, needs fast antibiotic treatment. Whether a narrower or broader drug should be first choice is debated.
Reviewing one hundred and four patients with confirmed target bacteria, the team found the narrower drug, amoxicillin with clavulanic acid, would have covered most cases. The broader third-generation drugs were chosen in a fifth of cases, and that choice was unjustified in most of them. Narrowing treatment later happened in only about a quarter of cases. Broader drugs seem overused, the authors say, pending wider confirmation.
Catalog record
| CREATOR | Quitterie Lostie de Kerhor, Zeina Sabouni, Cyrille Geay, Catherine Bouvet-Velly, Laurent Ducros, Jonathan Chelly |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36935 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |